The Patent Finder

Terms ending in 2037

BioAtla Inc.

Every in-force patent on BioAtla Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,822,426Humanized ANTI-CD73 Antibodies
In force
 · High confidence
Corvus Pharmaceuticals, Inc.In forceHigh confidence
US 11,859,007Humanized ANTI-CD73 Antibodies
In force
 · High confidence
Corvus Pharmaceuticals, Inc.In forceHigh confidence
US 11,472,876Conditionally Active Polypeptides
In force
 · Medium confidence
BioAtla, Inc.In forceMedium confidence
US 10,697,972Diagnostics Using Conditionally Active Antibodies
In force
 · High confidence
BioAtla, Inc.In forceHigh confidence
US 11,149,088Anti-Axl Antibodies, Antibody Fragments and Their Immunoconjugates and Uses Thereof
In force
 · High confidence
BioAtla, Inc.In forceHigh confidence
US 11,897,959Anti-Axl Antibodies, Antibody Fragments and Their Immunoconjugates and Uses Thereof
In force
 · Medium confidence
BioAtla, Inc.In forceMedium confidence
US 11,279,924Conditionally Active Polypeptides and Methods of Generating Them
In force
 · High confidence
BioAtla, Inc.In forceHigh confidence
US 11,254,742ANTI-ROR2 Antibodies, Antibody Fragments, Their Immunoconjucates and Uses Thereof
In force
 · High confidence
BioAtla, Inc.In forceHigh confidence
US 12,186,278Mesothelin Chimeric Antigen Receptor (CAR) and Antibody Against PD-L1 Inhibitor for Combined Use in Anticancer Therapy
In force
 · High confidence
Novartis AG and The Trustees of the University of PennsylvaniaIn forceHigh confidence
9 of 9 patents shown. Soonest term end first, then patent number.
6 of these are in force and held by BioAtla Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited